Gevo, Inc.
NASDAQ:GEVOChemicals - Specialty
+$0.04 today
- Market cap
- $420.54M
- Beta
- 0.99
- P/E (TTM)
- -10.7
- EPS (TTM)
- -$0.14
Volume 2.74M
Average 3.88M
GEVO Common Stock Issued
Cash raised by issuing new shares.
Gevo, Inc.NASDAQ: GEVO
Common Stock Issued · Q1 FY2026 · quarter ended Mar 2026
Common stock issued outflow grows to $172K
Q1 FY2026 common stock issued was $172K, compared with $0 a year earlier. Trailing-twelve-month common stock issued was $517K. Over 3 fiscal years it compounded at -82.5% a year.
Context
- Common stock issued amounted to 0.5% of revenue in FY2025, up 0.5 pp from a year earlier.
- Common stock issued increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly common stock issued holds near $172K or moves back toward the trailing-twelve-month quarterly average of $129.25K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Common Stock Issued history
USD · from the cash flow
- Latest · FY2025
- 798K USD
- Year-over-year change
- —
- 4-year CAGR
- -79.9%
| Period | Period end | Common Stock Issued | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 798K | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | -100.0% |
| FY2022 | 2022-12-31 | 150M | -69.3% |
| FY2021 | 2021-12-31 | 489.37M | — |
Common Stock Issued vs competitors
How GEVO compares with its peers on the latest reported figures
- Peers report in different currencies, so common stock issued is compared through growth and share of revenue rather than absolute size.
- Common stock issued amounts to 0.3% of revenue for GEVO, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CA$87.98M CAD | +429.3% | +16.2% | 560.6% | |
ADURAduro Clean Technologies Inc. | LTM Feb 2026 | CA$46.48M CAD | +213.6% | +69.1% | 19214.8% |
| LTM Mar 2026 | $43.81M USD | +313.4% | +44.2% | 18020.1% | |
| LTM Mar 2026 | $1.2M USD | -42.9% | +8.4% | 0.1% | |
| LTM Mar 2026 | $517K USD | — | -82.5% | 0.3% | |
| LTM Mar 2026 | $267K USD | -54.5% | -41.1% | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding GEVO) | — | +213.6% | +16.2% | 0.0% | |
Competitors are the stored peer set for GEVO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (59.2M) | (98.01M) | (66.22M) | (78.64M) | (32.63M) |
| Depreciation & Amortization | 5.13M | 7.89M | 19.01M | 18.3M | 27.34M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | (52.03M) |
| Stock-Based Compensation | 9.87M | 17.42M | 17.09M | 14.73M | 9.21M |
| Change in Working Capital | (13.68M) | (458K) | (24.4M) | (14.27M) | 34.76M |
| Accounts Receivables | (257K) | 502K | (2.15M) | 417K | (1.01M) |
| Inventory | (259K) | (2M) | 670K | (706K) | (4.06M) |
| Accounts Payables | (271K) | 3.64M | 0 | 0 | 5.28M |
| Other Working Capital | (12.9M) | (2.59M) | (22.93M) | (13.98M) | 34.56M |
| Other Non-Cash Items | 9.61M | 28.85M | 806K | 2.5M | (57K) |
| Operating Cash Flow | (48.27M) | (44.31M) | (53.72M) | (57.38M) | (13.4M) |
| Capital Expenditures | (65.94M) | (84.09M) | (54.46M) | (51.09M) | (30.11M) |
| Acquisitions (Net) | 0 | 0 | 0 | (6.07M) | (191.46M) |
| Purchases of Investments | (424.99M) | (130.4M) | 0 | 0 | 0 |
| Sales of Investments | 79.57M | 299.58M | 168.55M | 0 | 0 |
| Other Investing Activities | (9.17M) | (10K) | 34K | 5.34M | 0 |
| Investing Cash Flow | (411.36M) | 85.09M | 114.13M | (51.82M) | (221.57M) |
| Debt Repayment | 68.83M | (162K) | (189K) | (1.04M) | 93.54M |
| Common Stock Issued | 489.37M | 150M | 0 | 0 | 798K |
| Common Stock Repurchased | 0 | 0 | 0 | (4.71M) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (40.88M) | (11.28M) | 0 | (1.62M) | (1.45M) |
| Financing Cash Flow | 517.32M | 138.56M | (189K) | (7.36M) | 92.88M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 61.15M |
| Net Change in Cash | 57.7M | 179.34M | 60.22M | (116.56M) | (80.95M) |
| Free Cash Flow | (114.21M) | (128.4M) | (108.17M) | (108.47M) | (43.51M) |
Gevo, Inc.
NASDAQ:GEVO
Intrinsic Alpha fair value
Locked
Current Price
$1.70
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.